Some of the most interesting innovations are not single-use solutions. They are platforms.

Aqua Medical has built exactly that with its radiofrequency vapor ablation system. Initially developed for treating Barrett’s esophagus and GI lesions, the platform delivers controlled, uniform ablation with a strong safety profile.

What stands out is how this same core technology is being extended to new areas, including metabolic conditions such as Type 2 diabetes.

It is a thoughtful approach to design that creates flexibility and long-term relevance.

This is how innovation compounds over time.

Congratulations to Aqua Medical, the winner of the TAG Award for Medical Devices: Endoscopic Therapeutic Innovation, recognized for building a scalable platform across gastrointestinal and metabolic care.